Globus Medical (GMED) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

GMED Globus Medical

Watchlist

82.420
-0.290-0.35%

Close Dec 13 16:00 ET

82.420
0.0000.00%

Post 20:01 ET

11.22BMarket Cap132.94P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Jefferies Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $100
Moomoo NewsDec 12 08:31 ET · Ratings
Globus Medical (GMED) Gets a Buy From Jefferies
TipRanksDec 12 08:25 ET · Ratings
CCORF Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $92
Moomoo NewsDec 12 07:33 ET · Ratings
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $91
Moomoo NewsDec 12 07:33 ET · Ratings
Globus Medical Price Target Raised to $91 From $87 at BTIG
TipRanksDec 12 07:26 ET
Bone Marrow Aspirate Concentrates Industry Report, Featuring Profiles of 45+ Key Players Including Arthrex, Cesca Therapeutics, Globus Medical, Ranfac, Terumo and Zimmer Biomet Holdings
Yahoo FinanceDec 11 11:39 ET

Comments

whqqq

Aug 8 01:51

Arm Holdings, Upstart, Globus Medical Get Analyst Cheer, Retail Bullish On Just Two Names

Retail investors are positive about Upstart and Globus Medical but remain undecided on Arm Holdings as guidance remains sluggish.
Wall Street started Wednesday positively, with major indices rising nearly 1%. Analysts have added to the optimism with upgrades in the semiconductor, financials, and healthcare sectors. Here’s what Bernstein, Citi, and Wells Fargo analysts think:
1. Arm Holdings ( $Arm Holdings (ARM.US)$ ): ...

Moomoo AI

Feb 5 19:27

The company's CEO, Dan Scavilla, expressed confidence in Pfeil's ability to drive operational efficiency and deliver profitable growth, especially in light of the ongoing integration following their merger with NuVasive.

Press Release: Globus Medical Promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer

Moomoo AI

Dec 22, 2023 07:10

Globus Medical's superior earnings outlook is contributing to its high P/E, which shareholders are currently comfortable with, expecting not to face a threat to future earnings. The confidence in the future earnings performance supports the current share price.

Why Investors Shouldn't Be Surprised By Globus Medical, Inc.'s (NYSE:GMED) P/E

Moomoo AI

Nov 9, 2023 08:06

Globus Medical's persisting issues impact its valuation and a drop in EPS may spark shareholder worry. The long-term share performance is lackluster, unsettling even potential contrarian investors seeking a turnaround.